Results
7
Companies which are more than 50% undervalued based on analyst price target.
7 companies
Emcure Pharmaceuticals
Market Cap: ₹174.2b
Engages in the developing, manufacturing, and marketing pharmaceutical products worldwide.
EMCURE
₹919.45
7D
-1.9%
1Y
n/a
Akums Drugs and Pharmaceuticals
Market Cap: ₹68.3b
Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.
AKUMS
₹433.80
7D
2.9%
1Y
n/a
Strides Pharma Science
Market Cap: ₹56.7b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally.
STAR
₹615.30
7D
6.9%
1Y
-26.0%
Shilpa Medicare
Market Cap: ₹55.6b
Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, recombinant albumin in India, the United States, Europe, and internationally.
530549
₹640.10
7D
5.1%
1Y
25.7%
Orchid Pharma
Market Cap: ₹36.5b
A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
ORCHPHARMA
₹719.70
7D
-0.09%
1Y
-34.5%
Senores Pharmaceuticals
Market Cap: ₹25.5b
Develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally.
SENORES
₹553.40
7D
8.2%
1Y
n/a
Tarsons Products
Market Cap: ₹18.7b
Manufactures and trades in scientific plastic labware products in India and internationally.
TARSONS
₹352.20
7D
3.3%
1Y
-22.3%